Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Opuntia ficus-indica seed oil, commonly known as prickly pear seed oil, is a lipid-rich extract derived from the seeds of the *Opuntia ficus-indica* cactus. It is characterized by a high content of unsaturated fatty acids, particularly linolenic and linoleic acids, as well as significant concentrations of tocopherols (Vitamin E) and phytosterols such as campesterol and sitosterol. The oil is studied for its diverse biological activities, including potent antioxidant properties, antimicrobial efficacy against strains like *Saccharomyces cerevisiae*, and antiviral activity against Herpes Simplex Virus type 2 (HSV-2). Furthermore, it has shown potential as an antineoplastic agent, specifically exhibiting inhibitory effects on PC-3 prostate carcinoma cells. It is traditionally used in food and medicine and is considered a promising candidate for the management of non-communicable diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on opuntia ficus-indica seed oil.